Analystreport

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at Morgan Stanley from $162.00 to $176.00. They now have an "equal weight" rating on

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com